Biotheranostics and hologic
WebFeb 23, 2024 · Hologic (NSDQ: HOLX) announced that it completed its previously announced acquisition of Biotheranostics for $230 million. Marlborough, Mass.-based Hologic last month announced that it was … WebBreast Cancer Index™ (BCI), performed by Biotheranostics, Inc., is the only test that is …
Biotheranostics and hologic
Did you know?
WebJan 6, 2024 · Medical technology company Hologic Inc. has announced the acquisition of privately-held Biotheranostics Inc. in a deal worth $230 million. Shares of Hologic, which closed 4% higher on Tuesday ... WebMar 22, 2024 · Hologic Inc. (NASDAQ: HOLX), a global leader in women’s health, announced at the beginning of the year that it had forged an agreement to acquire Biotheranostics Inc., a private, commercial-stage company focused on molecular diagnostic tests for breast and metastatic cancers. The biotech acquision is worth …
WebSeasonal Variation. Generally, the summers are pretty warm, the winters are mild, and … WebBiotheranostics, Inc. (BTX) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. BTX does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. ... Hologic, Biotheranostics, Breast Cancer Index ...
WebBiotheranostics is a commercial-stage molecular diagnostics company that support physicians in the treatment of cancer patients. Acquired by. Hologic. San Diego, California, United States. 11-50. Venture - Series Unknown. WebNov 1, 2024 · Hologic’s management will host a conference call at 4:30 p.m. ET today to discuss its financial results for the fourth quarter of fiscal 2024. Interested participants may listen to the call by dialing 800-458-4121 (in the U.S. and Canada) or +1 323-794-2093 (for international callers) and referencing access code 2820462.
WebHologic offers a space for employees to own their passion and feel a sense of purpose …
WebJan 8, 2024 · Hologic, Inc. HOLX recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company providing molecular diagnostic tests for breast and metastatic cancers ... lithobiesWebLonger term, while Biotheranostics currently markets its products only in the US, Hologic plans to leverage its own sales and marketing teams to promote them internationally. Also in the long run, Hologic may configure Biotheranostics' tests to run on Hologic's Panther Fusion platform, Thornal added. ims ltd birminghamWebJan 5, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, … lithobie animalWebFeb 23, 2024 · Hologic (NSDQ: HOLX) announced that it completed its previously … i ́m smacking the hoeims lucknow university mba syllabusWebBeing part of Hologic only helps bring that hope closer to reality. In addition, patients … lithobie imageWebHologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging. ... In January 2024, the company announced it would acquire Biotheranostics and its breast and metastatic cancer test portfolio for $230 Million and SOMATEX for $64 Million. lithobie insecte